We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gene Expression Kit Designed for High-throughput Automated Usage

By LabMedica International staff writers
Posted on 04 Oct 2015
A newly released kit for gene expression measurement was designed for high-throughput use with 384-well microplates.

The Affymetrix (Santa Clara, CA, USA) QuantiGene Singleplex Assay does not require nucleic acid purification, reverse transcription, or PCR amplification. More...
Packaged for use on 384-well microplates, the assay is readily adaptable for automated high-throughput screening.

The manufacturer recommends using the QuantiGene assay for screening of compounds in drug discovery, for biomarker validation, and in siRNA (small, inhibiting RNA) knockdown studies. The assay works with a wide range of sample types, including heavily degraded and cross-linked RNA in FFPE (formalin fixed paraffin embedded) samples and RNA circulating in blood.

“This new, automation-friendly 384-well assay format fits with current workflows because cells are most commonly cultured in 384-well plates for high-throughput screening,” said Brian McLucas, product manager at Affymetrix. “Furthermore, the limiting step with qPCR is RNA purification, which is completely avoided with QuantiGene assays. Gene expression-based high-throughput screening of hundreds of thousands of compounds can be carried out in just weeks.”

Related Links:
Affymetrix


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Thyroid Test
Anti-Thyroid EIA Test
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.